MENU
NONOF
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION
Novo-Nordisk A/S (NONOF) Ownership - Who owns Novo-Nordisk A/S?
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world... Show more
Profile
Industry
N/A
Address
Novo Alle 1
Phone
+45 44448888
Employees
64319
Web
https://www.novonordisk.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
299.64B
P/E Ratio
20.51
Total Cash
26.31B
Projected Growth
1.04
Total Debt
102.79B
Revenue
290.4B
Risk (Beta)
0.39
Dividend Yield
0.02
Total Cash/Share
5.93
Total Debt/Equity
N/A
Revenue/Share
9.41 USD as % of share price
Fundamentals
NONOF
Capitalization
300B
P/E Ratio
20.51
Risk (Beta)
0.39
Dividend Yield
0.02
Total Cash
26.3B
Total Cash/Share
5.93
Total Debt
103B
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
1.04
Revenue/Share (as % of the share price)
9.41%
Revenue
290B
ROE
N/A
Book Value
143B
P/B Ratio
14.37
Cash Flow
N/A
Earnings
22.67
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
446M
Current Ratio
0.74
Current Revenue Per Employee
1122945.60
Dividends Per Share - Security
0.00
EBITDA
137B
Float
N/A
Float - Current
N/A
Gross Income Margin
84.80
Revenue To Assets
25.89
Shares Held By Institutions
377B
Shares Outstanding - Current
4.44B
Total Liabilities
322B
Total Volume MTD
N/A
Value
1
Gain YTD
-21.834
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
Novo Alle 1
Phone
+45 44448888
Employees
64319
Web
https://www.novonordisk.com